Hellenic PCI Registry Organization - Structure - Directions - Initial Recordings http://registry.hellenicpci.gr/ Georgios I. Papaioannou, MD, MPH, FACC,

Slides:



Advertisements
Similar presentations
Decline in the Use of Drug-Eluting Stents for Patients With NSTEMI Undergoing PCI: Results From the CRUSADE and ACTION Registries Matthew T. Roe, Christopher.
Advertisements

Radial versus Femoral Randomized Investigation in ST Elevation Acute Coronary Syndrome the RIFLE STEACS study Enrico Romagnoli, MD PhD Principal investigators:
A Risk Score for Predicting Coronary Artery Bypass Surgery in Patients with Non-ST Elevation Acute Coronary Syndromes Sai Sadanandan, MD*; Christopher.
CPORT- E Trial Randomized trial comparing medical, economic and quality of life outcomes of non-primary PCI at hospitals with and without on-site cardiac.
BWGIC survey Victor Legrand Yves Taeymans. PCI 2004 : procedures n=
WG Hellenic PCI Registry Organization - Structure - Directions - Initial Recordings Georgios I. Papaioannou, MD,
Chaim Lotan MD, Yaron Almagor MD, Karel Kuiper MD, M.J. Suttorp MD, William Wijns MD The SICTO Study CYPHER TM Sirolimus-eluting stent in Chronic Total.
Hamon M 1, Nienaber C 2, Galli S 3, Huber K 4, Gulba D 5, Hill J 6, Lafont A 7, Cequier A 8, Bernstein D 9, Deliargyris E 9 Institutions: 1. Centre Hospitalier.
ICE Hellenic PCI Registry Organization - Structure - Directions - Initial Recordings Georgios I. Papaioannou, MD,
CPORT- E Trial Randomized trial comparing outcomes of non-primary PCI at hospitals with and without on-site cardiac surgery.
Female Gender Is An Independent Predictor Of In-Hospital Mortality After STEMI In The Era of Primary PCI. Insights From The Greater Paris Area PCI Registry.
Tarunjit Singh Department of Internal Medicine Westchester Medical Center New York Medical College Valhalla NY.
Athens Cardiology Update CADILLAC Study Blood Transfusion after Myocardial Infarction: Friend, Foe or double-edged Sword? Georgios I. Papaioannou,
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
AICT 2010-Athens Interventional Cardiovascular Therapeutics XI 8-9 OCTOBER 2010 Divani Caravel Hotel, Αthens EARLY CLINICAL OUTCOMES AFTER PROMUS ELEMENT.
Bleeding in Patients Undergoing Percutaneous Coronary Interventions: A Risk Model From 302,152 Patients in the NCDR. Sameer K. Mehta MD, Andrew D. Frutkin.
Left Main Trifurcation Disease: Early and Long-Term Outcomes Of Percutaneous Coronary Intervention I.Sheiban, A.Gerasimou, F. Sciuto, P.Omedè, G. Biondi.
ICE Hellenic PCI Registry Organization - Structure - Directions - Initial Recordings Georgios I. Papaioannou, MD,
ΕΚΕ Hellenic PCI Registry ( ) Περιεχόμενο και αναγκαιότητα διατήρησης Registry Αγγειοπλαστικής Georgios.
LONG-TERM OUTCOMES OF PERCUTANEOUS CORONARY INTERVENTION FOR UNPROTECTED LEFT MAIN CORONARY ARTERY DISEASE: INITIAL CLINICAL EXPERIENCE. Graidis Ch. 1,
Global Advisory Board Meeting Case Presentation Georgios I. Papaioannou, MD Athens Medical Center Cardiac Catheterization Laboratory.
Allen Jeremias, Neal Kleiman, Deborah Nassif, Wen-Hua Hsieh, Michael Pencina, Kelly Maresh, Manish Parikh, Donald Cutlip, Ron Waksman, Steven Goldberg,
Gender Differences in Long-Term Outcomes Following PCI of Patients with Non-ST Elevation ACS: Results from the ACUITY Trial Alexandra J. Lansky on behalf.
Dr.Ali Eshraghi MD Interventional Cardiologist Non STE ACS  Angiographic Findings: 34% 3VD 28%2VD 26%SVD 10%LMCAD Culprit lesion charactristic: eccentric,scalloped,evidence.
Issued in 2014 – SCAAR. SCAAR Annual report 2013.
Issued in 2015 – SCAAR. SCAAR Annual report 2014.
Cardioprotective Effects of Postconditioning in Patients Treated with Primary PCI Evaluated with Magnetic Resonance Jacob T Lønborg Niels Vejlstrup, Erik.
The OPTIMAX first-in-man study Mid-term clinical outcome of Titanium-Nitride-Oxide-coated Cobalt Chromium stents in patients with de novo coronary artery.
A Clinical profile of patients enrolled in the Pakistan ACS registry
Latvian Centre of Cardiology real-life registry
Gregg W. Stone MD for the ACUITY Investigators
Interesting Case Presentation
Final Five-Year Follow-up of the SYNTAX Trial: Optimal Revascularization Strategy in Patients With Three-Vessel Disease and/or Left Main Disease Patrick.
PCI related in-hospital mortality based on race and gender in the USA
Tarek Abou Ghazala, MD, FACC, FSCAI
Carotid Artery Stenting Predictors of procedural and clinical success
Procedural factors associated with PCI-related ischemic stroke
BVS Expand: First Results of Wide Clinical Applications
Stent Thrombosis Rates in Contemporary Clinical Practice: Insight from a Large Australian Multi-centre Registry BP Yan*, TJ Kiernan, SJ Duffy, DJ Clark,
Complication Rates for Percutaneous Coronary Intervention in South Australia Aashray Gupta1, Rosanna Tavella1,2, Margaret Arstall1,3, Matthew Worthley1,2,
Is There a Role for Aspiration in STEMI?
On behalf of J. Belardi, M. Leon, L. Mauri,
FINAL FIVE-YEAR CLINICAL OUTCOMES OF THE NOBORI2 TRIAL
Two-Year Extended Follow-up in Patients Receiving a Zotarolimus-eluting Stent in the E-Five Registry Martin T. Rothman, Ian T. Meredith, Keyur Parikh,
Using Coronary CTA to Guide Intervention for CTO
Glenn N. Levine et al. JACC 2016;68:
Long-term follow-up of the DIABETES I (DIABETes and sirolimus Eluting Stent) trial: P Jiménez-Quevedo, M Sabaté, DJ Angiolillo, JA Gómez-Hospital, R Hernández-Antolín,
Incidence And Management Of Restenosis After Treatment Of Unprotected Left Main Disease With Drug-Eluting Stents: 70 Restenotic Cases From A Cohort Of.
Giuseppe Biondi Zoccai, MD
2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease  Glenn N. Levine, MD, FACC, FAHA,
Efficacy of Xience/Promus versus Cypher to rEduce Late Loss in stENT
Impact of clopidogrel loading dose on the safety and effectiveness of bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction:
Real World Data on Stent Thrombosis: The Spanish ESTROFA registry
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
Large-Scale Registry Examining Safety and Effectiveness of Zotarolimus-Eluting and Sirolimus-Eluting Stents in Patients with Coronary Artery Disease Western.
SIRIUS: A U.S. Multicenter, Randomized, Double-Blind Study of the SIRolImUS-Eluting Stent in De Novo Native Coronary Lesions Presented at TCT 2002.
Impact of Platelet Reactivity Following Clopidogrel Administration
STENT THROMBISIS Insights on Outcomes and Impact of DUAL ANTIPLATELET THERAPY Permanent Discontinuation SPIRIT II, SPIRIT III, SPIRIT IV and COMPARE.
Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents: 70 restenotic cases from a cohort of.
12-month clinical and 13-month angiographic outcomes from a randomized trial evaluating the Absorb Bioresorbable Vascular Scaffold vs. metallic drug-eluting.
Gregg W. Stone, MD Columbia University Medical Center
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
China PEACE risk estimation tool for in-hospital death from acute myocardial infarction: an early risk classification tree for decisions about fibrinolytic.
Long Term Clinical Results from the Endeavor Program: 5-Year Follow up
Maintenance of Long-Term Clinical Benefit with
DEScover: One-Year Clinical Results
Angioplasty Balloon-associated Coronary Debris and the EZ FilterWire
Ahmed A. Khattab, MD For the German Cypher Registry Investigators
Atlantic Cardiovascular Patient Outcomes Research Team
The American College of Cardiology Presented by Dr. A. Abazid
Presentation transcript:

Hellenic PCI Registry Organization - Structure - Directions - Initial Recordings http://registry.hellenicpci.gr/ Georgios I. Papaioannou, MD, MPH, FACC, FSCAI Athens Medical Center Cardiac Catheterization Laboratory 18/1/2010 WG 2010

Aim of the Hellenic PCI Registry (2008-2010) Common link with ESC (ESC PCI Registry) and EAPCI Recording of Centers/Operators/ Interventional Coronary Procedures with regional and national analyses Recording of basic indications, demographic, procedural and outcomes data of patients undergoing PCI National database for educational and professional requirements (in accordance to ESC/ACC) Quality and Outcomes Research WG 2010

Registries & Clinical Practice WG 2010

Hellenic Heart Registry on PCI Initial attempt in 1998 – paper based Current decision of the WG of HSC for a f/u attempt Analyses at a national level & submission of data to the ESC Web-based database with secure data entry by individual users (user ID/password) Central analyses of data by the WG of HSC Each center may use the database for their own data analyses upon request WG 2010

Timetable of the PCI Registry 5/2006: WG decision 7/2006: Funding for the initial phase 9/2006: Collaboration with Philip Lees (Webmaster) 12/2006: Early design of database 3/2007: Testing version in a separate domain (Phase I) 7/2007: Phase II – Pilot cases entry (>300 patients, 9 centers) 2/2008: Phase III – Official start of Registry retrospectively from 1/1/2008 with a 3-5 year plan (>2500 patients entered so far) 2/2010: 2 year completion – Decision about further continuation with existing participation - Data analysis WG 2010

Tables (8) Patient (Automatic entry ID-Demographics-Patient initials) Workup (History-Risk factors-Indication-Times-Admission Medications) PCI Angiogram (Angiographic findings based on the 15-segment model of ESC) PCI Procedure (Periprocedural medications-Additional diagnostic or theurapeutic devices-Complications) PCI Lesions (Lesion characteristics-PCI device-Result) Outcome (In-hospital outcome) Follow up (1 year/3 years/5 years) Submit (Automatic initial validation) WG 2010

ESC 15 Segment Model WG 2010

Centers/Operators/CABG on site: 2007 & 2008 WG 2010

New PCI Centers: 2008 & 2009 WG 2010

PCI Centers: 2009 Status WG 2010

COR/PCI Procedures: 2007 & 2008 2007 2008 WG 2010

COR Procedures: 2007 & 2008 2007 2008 WG 2010

PCI Procedures: 2007 & 2008 2007 2008 WG 2010

COR & PCI Procedures / 106 population: 2007 & 2008 (10,9 million) WG 2010

PCI Volume per Center: 2007 & 2008 WG 2010

PCI Centers & Primary PCI - 2008 *Technical ability to perform primary PCI WG 2010

Primary PCI numbers*: 2007 * Data from 27 Centers (6 Centers with data missing ) WG 2010

Primary PCI numbers: 2008 9,6% 7,2% 1,25% 1,15% WG 2010

Volume of Primary PCI per Center 2007 2008 WG 2010

Hellenic PCI Registry (2/2008-10/2009) n=2654 patients: Demographics Males 2221 (83.6%) Females 433 (16.4%) Age 64.1 ± 10.8 Height 169.9 ± 10.8 Weight 81.6 ± 14.6 BMI 28.6 ± 1.2 WG 2010

Hellenic PCI Registry (2/2008-10/2009) n=2654 patients: Demographics Hx Stable Angina 734 (27.6%) Hx Prior MI 660 (24.9%) Hx CVA 51 (1.9%) Hx PVD 132 (5%) Hx of CRF 66 (2.5%) Hx Prior PCI 543 (20.5%) Hx Prior CABG 225 (8.5%) Current Smokers 1007 (37.9%) Former Smokers 828 (31.2%) Current Diabetes 781 (29.4%) Hypertension 1792 (67.5%) Dyslipidemia 1767 (66.5%) WG 2010

Hellenic PCI Registry (2/2008-10/2009) n=2654 patients: PCI Indication Elective PCI* 1261 (47.5%) ACS (UA/NSTEMI) 313 (11.8%) STEMI 248 (9.3%) ACS stabilized 426 (16.1%) STEMI stabilized 334 (12.6%) Other 72 (2.7%) *Stable angina/documented ischemia WG 2010

Hellenic PCI Registry (2/2008-10/2009) n=582 STEMI patients: Type of Therapy Thrombolytic Rx 186 (31.9%) Primary PCI 248 (43%) Post STEMI PCI 334 (57%) WG 2010

Hellenic PCI Registry (2/2008-10/2009) n=2654 patients: Angio Data EF >50% 1866 (70.4%) 30%EF50% 457 (17.2%) EF<30% 110 (4.1%) EF Unknown 221 (8.3%) LM>50% 73 (2.7%) 1VD 1354 (51%) 2VD 838 (31.6%) 3VD 462 (17.4%) Treated LM 9 (0.3%) Treated LAD 1357 (51.1%) Treated CX 847 (31.9%) Treated RCA 1055 (39.8%) Treated by-pass graft 58 (2.2%) WG 2010

Hellenic PCI Registry (2/2008-10/2009) n=2654 patients: PCI Data Femoral Access 2436 (91.8%) Radial Access 110 (4.2%) IVUS 59 (2.2%) Pressure wire 38 (1.4%) IABP 7 (0.2%) Distal Protection 12 (0.4%) Thrombectomy 112 (4.2%) WG 2010

Hellenic PCI Registry (2/2008-10/2009) n=2654 patients: PCI Data Type A lesion 14% Type B lesion 63% Type C lesion 27% Mean No stents per lesion 1.2 Mean stent size (mm) 2.8 Mean stent length (mm) 17.4 BMS stenting 40.7% DES stenting 59.3% Clopidogrel 300 mg 1994 (75%) Clopidogrel 600 mg 597 (22.5%) GP IIbIIIa inhibitors 355 (13.4%) WG 2010

Hellenic PCI Registry (2/2008-10/2009) n=2654 patients: Complications & Outcomes Periprocedural complications 85 (3.2%) Acute segment closure 19 (0.7%) Side branch occlusion 25 (0.9%) Distal embolization 13 (0.5%) No flow/slow flow 26 (1%) In hospital death 6 (0.2%)* Periprocedural MI 18 (0.7%)* Periprocedural CVA 7 (0.3%) Stent thrombosis 9 (0.3%) Repeat PCI 16 (0.6%) Emergency CABG Major bleed 15 (0.6%) Renal failure * 1.2% ESC PCI Registry WG 2010

Difficulties & Problems Motivation of physicians (multifactorial) Politics Clear understanding of the role and the benefits of the registry with broad participation in analyses Establish a structure especially in high-volume centers for secretarial help Loss of enthusiasm of existing users if a wide participation can not be achieved Minimal increase in participation in year 2008 WG 2010

2010 Proposal to WG Continue keeping the existing structure of the Database (web site – server) Complete a 2 year recording (2/2010) Perform analyses of the data and f/u Discussion in the WG regarding ways to expand participation for further continuation of the Database WG 2010

EAPCI Data ESC effort to collect “minimal” basic interventional data – effort to record practices and patterns across Europe (obligatory) Started in 2006 – Data submitted for 2007 & 2008 2009 data should be collected in a more precise pattern retrospectively Monthly forms created for 2010 (prospective collection) We should all participate! WG 2010

EAPCI Form WG 2010

Hellenic Heart Registry on Percutaneous Coronary Interventions Link: http://registry.hellenicpci.gr/ Επικοινωνία: admin@hellenicpci.gr gpapaio@otenet.gr athanasios_kotsanis@hotmail.com ananou@cc.uoi.gr Thank you for your participation! WG 2010